WASHINGTON (AP) The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agenc… [+10082 chars]
FDA's new expedited drug program raises legal questions and concerns - PBS
The FDA commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency.
Source:PBS
Published:
Related News
Trump Tariff Threat to Weigh on Risk Sentiment, European Stocks - Bloomberg.com
US President Donald Trump’s announcement of new tariffs on eight European countries over Greenland weighed on risk sentiment as trading kicked off Monday.
Bloomberg•Farah Elbahrawy, Julien Ponthus
Sequoia to invest in Anthropic, breaking VC taboo on backing rivals: FT - TechCrunch
Sequoia Capital is reportedly joining a blockbuster funding round for Anthropic, the AI startup behind Claude, according to the Financial Times. It's a
TechCrunch•Connie Loizos
EPA Rule Clarification Hits a Significant Source of Grok’s Electricity - Gizmodo
It seems xAI has been taking liberties with gas turbines that federal rules don’t actually tolerate.
Gizmodo.com•Mike Pearl